Commentary: J Clin Exp Nephrol (1-2)
Serum Soluble Urokinase Plasminogen Activator Receptor as a Potential Biomarker
Author(s): Mostafa Ibrahim
DOI: 10.36648/2472-5056.8.01.175
Opinion Article: J Clin Exp Nephrol (1-2)
Managing the Patient with Epilepsy and Renal Impairment
Author(s): Catapano Louie
DOI: 10.36648/2472-5056.8.01.176
Perspective Article: J Clin Exp Nephrol (1-2)
Toxicity and Survival Outcomes of Autologous Stem Cell Transplant
Author(s): Isabelle Monreal
DOI: 10.36648/2472-5056.8.01.177
Opinion Article: J Clin Exp Nephrol (1-2)
Renal Artery Partial Occlusion after Aortic Dissection
Author(s): Maria Sebastian
DOI: 10.36648/2472-5056.8.01.178
Perspective Article: J Clin Exp Nephrol (1-2)
Sodium-Glucose Cotransporter-2 Inhibitors and Protection against Stroke
Author(s): Amir Krystal
DOI: 10.36648/2472-5056.8.01.179
Commentary: J Clin Exp Nephrol (1-2)
Author(s): Wang Yin
DOI: 10.36648/2472-5056.8.1.181
Commentary: J Clin Exp Nephrol (1-2)
Cytokines and Inflammation in Primary Membrane Nephropathy
Author(s): David Roy
DOI: 10.36648/2472-5056.8.1.182
Opinion Article: J Clin Exp Nephrol (1-2)
Emerging Patterns of Children with Chronic Kidney Disease
Author(s): Joseph Martin
DOI: 10.36648/2472-5056.8.1.183
Commentary: J Clin Exp Nephrol (1-2)
Polycystic Kidney Sickness of Cell Flagging Pathways by Utilizing ADPKD
Author(s): Javelin Khan
DOI: 10.36648/2472-5056.8.1.180
Opinion Article: J Clin Exp Nephrol (1-2)
Evaluation of Acute Kidney Damage
Author(s): William John
DOI: 10.36648/2472-5056.8.1.184